JP2004505004A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004505004A5 JP2004505004A5 JP2000610469A JP2000610469A JP2004505004A5 JP 2004505004 A5 JP2004505004 A5 JP 2004505004A5 JP 2000610469 A JP2000610469 A JP 2000610469A JP 2000610469 A JP2000610469 A JP 2000610469A JP 2004505004 A5 JP2004505004 A5 JP 2004505004A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- alkyl
- compound
- hydrogen
- oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *C(C(*)C(*)(*)*C1)C1S Chemical compound *C(C(*)C(*)(*)*C1)C1S 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12840099P | 1999-04-08 | 1999-04-08 | |
| US60/128,400 | 1999-04-08 | ||
| PCT/US2000/008337 WO2000061136A1 (en) | 1999-04-08 | 2000-03-30 | Anticonvulsant derivatives useful in lowering blood pressure |
| US09/538,182 | 2000-03-30 | ||
| US09/538,182 US6201010B1 (en) | 1999-04-08 | 2000-03-30 | Anticonvulsant derivatives useful in lowering blood pressure |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004505004A JP2004505004A (ja) | 2004-02-19 |
| JP2004505004A5 true JP2004505004A5 (https=) | 2007-02-15 |
| JP4825353B2 JP4825353B2 (ja) | 2011-11-30 |
Family
ID=26826549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000610469A Expired - Lifetime JP4825353B2 (ja) | 1999-04-08 | 2000-03-30 | 血圧を下げることに有用な抗痙攣薬誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6201010B1 (https=) |
| JP (1) | JP4825353B2 (https=) |
| AU (1) | AU775849B2 (https=) |
| CA (1) | CA2369091C (https=) |
| MX (1) | MXPA01010221A (https=) |
| NZ (1) | NZ514812A (https=) |
| WO (1) | WO2000061136A1 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7056890B2 (en) * | 1999-06-14 | 2006-06-06 | Vivus, Inc. | Combination therapy for effecting weight loss and treating obesity |
| US7553818B2 (en) * | 1999-06-14 | 2009-06-30 | Vivus, Inc. | Combination therapy for effecting weight loss and treating obesity |
| US7659256B2 (en) * | 1999-06-14 | 2010-02-09 | Vivus, Inc. | Combination therapy for effecting weight loss and treating obesity |
| US20080255093A1 (en) * | 1999-06-14 | 2008-10-16 | Tam Peter Y | Compositions and methods for treating obesity and related disorders |
| US7674776B2 (en) * | 1999-06-14 | 2010-03-09 | Vivus, Inc. | Combination therapy for effecting weight loss and treating obesity |
| US20080103179A1 (en) * | 2006-10-27 | 2008-05-01 | Tam Peter Y | Combination Therapy |
| US7790905B2 (en) * | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
| WO2004000284A1 (en) * | 2002-06-21 | 2003-12-31 | Transform Pharmaceuticals, Inc. | Pharmaceutical compositions with improved dissolution |
| US20100311701A1 (en) * | 2002-02-15 | 2010-12-09 | Transform Pharmaceuticals, Inc | Pharmaceutical Co-Crystal Compositions |
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| US20090088443A1 (en) * | 2002-02-15 | 2009-04-02 | Julius Remenar | Novel crystalline forms of conazoles and methods of making and using the same |
| US6559293B1 (en) * | 2002-02-15 | 2003-05-06 | Transform Pharmaceuticals, Inc. | Topiramate sodium trihydrate |
| CA2477923C (en) * | 2002-03-01 | 2021-02-23 | University Of South Florida | Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| US20070059356A1 (en) * | 2002-05-31 | 2007-03-15 | Almarsson Oern | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| US8183290B2 (en) | 2002-12-30 | 2012-05-22 | Mcneil-Ppc, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
| US6949518B1 (en) | 2003-06-25 | 2005-09-27 | Pao-Hsien Chu | Methods for treating macular degeneration with topiramate |
| WO2008027557A2 (en) * | 2006-08-31 | 2008-03-06 | Spherics, Inc. | Topiramate compositions and methods of enhancing its bioavailability |
| ES2555066T3 (es) | 2006-11-17 | 2015-12-28 | Supernus Pharmaceuticals, Inc. | Formulaciones de liberación sostenida de topiramato |
| ES2645719T3 (es) | 2006-12-04 | 2017-12-07 | Supernus Pharmaceuticals, Inc. | Formulaciones de topiramato de liberación inmediata mejoradas |
| US20090304789A1 (en) * | 2008-06-09 | 2009-12-10 | Thomas Najarian | Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders |
| US8580298B2 (en) | 2008-06-09 | 2013-11-12 | Vivus, Inc. | Low dose topiramate/phentermine composition and methods of use thereof |
| WO2013139292A1 (zh) | 2012-03-23 | 2013-09-26 | 中国人民解放军军事医学科学院毒物药物研究所 | 一种含辛弗林和托吡酯的联合产品 |
| CN103316026B (zh) | 2012-03-23 | 2016-05-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 含芬特明和托吡酯的联合产品及其制备方法 |
| CN102579367B (zh) | 2012-03-23 | 2014-03-12 | 中国人民解放军军事医学科学院毒物药物研究所 | 托吡酯缓释药物组合物、其制备方法及用途 |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| EP3883546A1 (en) | 2018-11-21 | 2021-09-29 | Rosemont Pharmaceuticals Ltd | Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| US5242942A (en) * | 1992-04-28 | 1993-09-07 | Mcneilab, Inc. | Anticonvulsant fructopyranose cyclic sulfites and sulfates |
| US5258402A (en) * | 1992-06-11 | 1993-11-02 | Mcneil-Ppc, Inc. | Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates |
| US5998380A (en) * | 1995-10-13 | 1999-12-07 | New England Medical Center Hospitals, Inc. | Treatment of migraine |
| AP1285A (en) * | 1996-06-28 | 2004-06-24 | Ortho Mcneil Pharm Inc | Anticonvulsant sulfamate derivatives useful in treating obesity. |
-
2000
- 2000-03-30 JP JP2000610469A patent/JP4825353B2/ja not_active Expired - Lifetime
- 2000-03-30 WO PCT/US2000/008337 patent/WO2000061136A1/en not_active Ceased
- 2000-03-30 AU AU40441/00A patent/AU775849B2/en not_active Ceased
- 2000-03-30 NZ NZ514812A patent/NZ514812A/en unknown
- 2000-03-30 US US09/538,182 patent/US6201010B1/en not_active Expired - Lifetime
- 2000-03-30 CA CA002369091A patent/CA2369091C/en not_active Expired - Fee Related
- 2000-03-30 MX MXPA01010221A patent/MXPA01010221A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004505004A5 (https=) | ||
| JP2002541199A5 (https=) | ||
| JP2003521471A5 (https=) | ||
| RU2159761C2 (ru) | Замещенные 4-биарилмасляные или 5-биарилпентановые кислоты или их производные, способы их получения, фармацевтическая композиция и способ лечения | |
| RU2003100076A (ru) | Противосудорожные производные, используемые для профилактики развития сахарного диабета и синдрома х | |
| JP4818516B2 (ja) | 化合物の抗菌剤としての新規な使用 | |
| RU95105587A (ru) | Оптически чистые соединения пиридинилметил сульфинил-1н-бензимидазола, их соли, способы получения, фармкомпозиция, способ лечения | |
| JP2003501474A5 (https=) | ||
| NO20100034L (no) | Fenofibrat farmasoytisk blanding som har hoy biotilgjengelighet og fremgangsmate for fremstilling av den | |
| JP2003500442A5 (https=) | ||
| AU4951196A (en) | Vaccines for plague | |
| AR017979A1 (es) | Formulaciones farmaceuticas de epotilonas, metodo para su preparacion y el uso de los mismos para la manufactura de un medicamento | |
| ATE19589T1 (de) | Pharmazeutische dreilagen-filmpraeparate mit lang anhaltender wirkung. | |
| EP1428821A8 (en) | Piperidin-4-yl amines with analgesic effect | |
| JP2003528808A5 (https=) | ||
| CA2399208A1 (en) | Nucleoside analogs with carboxamidine modified monocyclic base | |
| HUT77627A (hu) | 2,2-Diklór-alkánkarbonsavak, eljárás előállításukra és ezeket tartalmazó, inzulinrezisztencia kezelésére alkalmazható gyógyszerkészítmények | |
| AU2002239830A1 (en) | Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof | |
| JP2003514872A5 (https=) | ||
| CA2369091A1 (en) | Anticonvulsant derivatives useful in lowering blood pressure | |
| CA2345445A1 (en) | A composition for the prevention and/or treatment of atherosclerosis | |
| ATE50260T1 (de) | Purinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitung. | |
| JP2002536328A5 (https=) | ||
| IS4218A (is) | Hliðstæð aðferð við að framleiða skammvirk tvíhýdrópýridín | |
| BR9916860A (pt) | Método de reduzir colesterol do sangue e/outriglicerìdios do sangue em um indivìduo mamìfero,preparação em forma de unidade de dosagem, e,conjunto para administrar oralmente a mesma |